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Abstract
Cocaine is the third most common substance of abuse after cannabis and alcohol. The use of
cocaine as an illicit substance is implicated as a causative factor for multisystem derangements
ranging from an acute crisis to chronic complications. Vasospasm is the proposed mechanism
behind adverse events resulting from cocaine abuse, acute ischemic strokes (AIS) being one of
the few. Our study looked into in-hospital outcomes owing to cocaine use in the large
population based study of AIS patients. Using the national inpatient sample (NIS) database
from 2014 of United States of America, we identified AIS patients with cocaine use using
International Classification of Disease, Ninth Revision (ICD-9) codes. We compared
demographics, mortality, in-hospital outcomes and comorbidities between AIS with cocaine
use cohort versus AIS without cocaine use cohort. Acute ischemic strokes (AIS) with cocaine
group consisted of higher number of older patients (> 85 years) (25.6% versus 18.7%, p <0.001)
and females (52.4% versus 51.0%, p <0.001). Cocaine cohort had higher incidence of valvular
disorders (13.2% versus 9.7%, p <0.001), venous thromboembolism (3.5% versus 2.6%, p<0.03),
vasculitis (0.9% versus 0.4%, p <0.003), sudden cardiac death (0.4% versus 0.2%, p<0.02),
epilepsy (10.1% versus 7.4%, p <0.001) and major depression (13.2% versus 10.7%, p<0.007).
The multivariate logistic regression analysis found cocaine use to be the major risk factor for
hospitalization in AIS cohort. In-hospital mortality (odds ratio (OR)= 1.4, 95% confidence
interval= 1.1-1.9, p <0.003) and the disposition to short-term hospitals (odds ratio (OR)= 2.6,
95% confidence interval = 2.1-3.3, p <0.001) were also higher in cocaine cohort. Venous
thromboembolism was observed to be linked with cocaine use (OR= 1.5, 95% confidence
interval= 1.0-2.1, p < 0.01) but less severely than vasculitis (OR= 3.0, 95% confidence interval=
1.6-5.8, p <0.001). Further prospective research is warranted in this direction to improve the
outcomes for AIS and lessen the financial burden on the healthcare system of the United
States.
Categories: Neurology, Psychiatry, Quality Improvement
Keywords: cocaine abuse, acute ischemic stroke, cocaine dependence, stroke prevention, in-hospital
outcomes, national inpatient sample, mortality
Introduction
The use of cocaine as an illicit drug surged in the United States of America between 2002 and
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2007 and currently, it is the second most abused drug after cannabis and alcohol [1-3]. Among
the adults, the annual prevalence of cocaine use was 1.5%, while some states reported the
prevalence of 5.5% to 5.8% in the age group of 18 to 25 years. The United Nations Office on
Drugs and Crime and the European Monitoring Centre for Drugs and Drug Addiction has
reported an increase of cocaine use in particular parts of the world [4]. The burden of health
care due to cocaine dependence was reported high in the recent studies [4]. Around 23.9 million
people aged 12 years and above were reported using illicit drugs in 2012 according to data from
the National Survey on Drug Use and Health [5]. A recent study from a community hospital
found 2.3% people being cocaine positive during drug screening in the age group of 65 years
and older. In the USA, the areas of primary concern are the one rampaged with poverty and
poor education [6]
One report from the emergency department notes in the Detroit area in 2002 showed cocaine
use of around 182/100,000 of the population [7]. It is not merely a problem of one country;
rather it has turned into a global issue [1]. The cocaine use leads to the spectrum of
multisystem derangements ranging from mild intoxication to severe complications like acute
myocardial infarction, seizures and acute ischemic stroke [8]. Compared to the corresponding
peer groups in the general population, cocaine users tend to have four to eight times higher
mortality [9-10]. Use of cocaine is presumed to be one of the major risk factors for
cerebrovascular disease, including stroke. Acute ischemic stroke (AIS) is labeled as the third
leading cause of disability-adjusted life years [10].
Previous studies have reported a 19% increase in the incidence of strokes due to cocaine use in
the last two decades [11]. The rise in cocaine-associated morbidity and mortality posed it as a
major public health concern [11-12]. Impacts on health care economies due to stroke-related
disability is devastating owing to medical cost, rehabilitation cost and cost due to loss of
workforce. A direct or indirect burden of around $68.9 billion was imposed on the US healthcare
owing to strokes in 2009, a major part of which was comprised of strokes as a result of illicit
drugs use [2]. We aim to evaluate various factors associated with acute ischemic strokes (AIS)
risk and to develop the management strategies to mitigate mortality rates within cocaine-
induced stroke population.
Materials And Methods
Data source
We utilized the discharge data from the National Inpatient Sample (NIS) of the Healthcare Cost
and Utilization Project (HCUP) as a source. The NIS is an all-payer dataset that includes around
eight million (around 20% of the stratified sample) inpatient admissions and discharges from
almost 1050 USA hospitals, excluding long term care and rehabilitation facilities. The NIS data
set is unweighted and it results in the weighted estimate of the total discharge number of the
US population when we apply the discharge weight to the unweighted data. We excluded the
data of missing information such as age, gender, discharge condition or primary diagnosis. We
used the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-
CM) to identify admissions with the primary diagnosis of AIS. Since NIS is publicly available de-
identified database from Agency for Healthcare Research and Quality (AHRQ), it does not
require an approval from institutional review board (IRB). More details on the dataset content
and methods of collections are accessible on the HCUP website [13].
Patient selection
We looked into the NIS database of the year 2014 to identify all patients with AIS with ICD-9-
CM codes (433.01, 433.11, 433.21, 433.31, 433.81, 433.91, 434.01, 434.11, 434.91 and 436).
Current use of cocaine (dependence or abuse) was identified using the ICD-9-CM codes 304.20
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(cocaine dependence, unspecified), 305.62 (non-dependent cocaine use, episodic), 305.61 (non-
dependent cocaine use, continuous), 304.21 (cocaine dependence, continuous) and 304.22
(cocaine dependence, episodic) [14] (Appendix).
Variables
Demographic variables examined in this study included age group (1-17, 18-44, 45-64, 65-84
years and > 85), gender (male or female), race (white, Hispanic, Asian or Pacific Islander, Native
American and other) and payer source (Medicare, Medicaid, private pay, self-pay, no charge and
other). Based on existing literature, we searched and defined AIS risk factors using diagnosis
codes from ICD-9-CM mentioned in the appendix.
Statistical analysis
Statistical Package for the Social Science, version 22.0 (SPSS V.22.0, IBM Corp., Armonk, NY,
USA) was used for all the statistical analysis. The incidence of AIS hospitalization among
cocaine users and nonusers were determined by searching all available diagnosis fields for the
diagnosis of AIS. Further age stratification was performed of the population into groups of 1-17,
18-44, 45-64, 65-84 years and > 85 years. Pearson’s chi-square test was used for categorical
data and the independent sample T-test was used for continuous data. We used a multivariate
logistic regression model to assess the AIS outcomes of cocaine use. Standard weights from
HCUP were utilized to get the national weighted estimates of inpatient admissions. We defined
p-value less than 0.05 (p < 0.005) as the statistical significance.
Results
Baseline characteristics of acute ischemic strokes cohort
We identified the total of 584,115 patients with AIS by using the discharge data from NIS of the
year 2014. We further stratified cohorts into a cocaine use (N=1135) and non-cocaine use
(N=582980). The AIS with cocaine group consisted of higher number of older patients (> 85
years) (25.6% versus 18.7%, p <0.001), females (52.4% versus 51.0%, p <0.001) and whites
(89.2% versus 70.3%, p <0.001). Cardiovascular incidences that were higher in the cocaine
cohort versus non-cocaine cohort included valvular disorders (13.2% versus 9.7%, p <0.001),
venous thromboembolism (3.5% versus 2.6%, p <0.03), vasculitis (0.9% versus 0.4%, p <0.003),
and sudden cardiac death (0.4% versus 0.2%, p <0.02). The incidence of epilepsy was higher in
cocaine cohort (10.1% versus 7.4 %, p <0.001). The incidence of major depression was higher in
cocaine cohort (13.2% versus 10.7%, p <0.007). The incidences of other risk factors for AIS such
as atherosclerosis, cardiac circulatory anomalies, hypertension (complicated and
uncomplicated), elevated cholesterol, diabetes, transient ischemic attack (TIA), paralysis,
family history of stroke, deficiency anemia, coagulopathy, disorders of fluid and electrolytes
were significantly higher in the non-cocaine cohort (Table 1).
Variables AIS + NO Cocaine AIS + Cocaine P-value*
Unweighted admissions 116596 227  
Weighted admissions 582980 1135  
Age in years at admission                                                                              
Mean Age ± SD 69.87±15.01 72.91±14.29 <0.001
1-17 0.5% 0.0% <0.001
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18-44 4.6% 3.5% <0.001
45-64 28.6% 23.8% <0.001
65-84 47.5% 47.1% <0.001
>85 18.7% 25.6% <0.001
Died during hospitalization                                                                           
Did not die 93.1% 89.9% <0.001
Died 6.9% 10.1% <0.001
Disposition of Patient                                                                                     
Routine 32.3% 22.5% <0.001
To Short-term Hospitals 3.4% 11.3% <0.001
Other (SNF, ICF, Another facility) 43.4% 37.0% <0.001
Home Health Care 13.2% 18.1% <0.001
Against Medical Advice (AMA) 0.7% 0.9% <0.001
Died 6.9% 10.1% <0.001
Discharged alive, destinations unknown 0.1% 0.0% <0.001
Elective Vs. Non-elective Admissions                                                            
Non-elective 93.6% 98.2% <0.001
Elective 6.4% 1.8% <0.001
Indicator of Sex                                                                                                 
Male 49.0% 47.6% 0.346
Female 51.0% 52.4% 0.346
Primary Expected Payer                                                                                 
Medicare 65.7% 72.1% <0.001
Medicaid 9.0% 9.3% <0.001
Private including HMO 18.7% 16.4% <0.001
Self - Pay 4.1% 1.3% <0.001
No charge 0.4% 0.0% <0.001
Other 2.1% 0.9% <0.001
Race                                                                                                                   
White 70.3% 89.2% <0.001
Black 16.8% 6.3% <0.001
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Hispanic 7.3% 4.1% <0.001
Asian or Pacific Islander 2.4% 0.0% <0.001
Native American 0.5% 0.0% <0.001
Other 2.7% 0.5% <0.001
Co –morbidities
RA/CVD 2.7% 4.0% 0.009
Atherosclerosis 28.7% 25.6% 0.020
Acute Myocardial Infarction 4.6% 4.8% 0.667
Arrhythmia 0.3% 0.4% 0.204
Sudden Cardiac Death 0.2% 0.4% 0.024
Cardiac Circulatory Anomalies 3.0% 1.3% <0.001
Heart Valve Disorders 11.2% 14.1% 0.002
Vasculitis 0.4% 0.9% 0.003
Hypertension 79.8% 72.2% <0.001
Elevated BP without Hypertension 0.2% 0.0% 0.106
Elevated Cholesterol 54.7% 42.3% <0.001
Venous Thromboembolism 2.6% 3.5% 0.039
Viral Infection 0.6% 0.0% 0.007
Pulmonary Circulation Disorders 4.1% 6.2% <0.001
Paralysis 10.0% 7.5% 0.005
Transient Ischemic Attacks 1.1% 0.0% <0.001
Family History of Stroke 2.3% 0.4% <0.001
Acute but ill-defined Cerebrovascular Disease 0.3% 0.0% 0.091
Epilepsy 7.4% 10.1% <0.001
Other neurological disorders 5.5% 2.6% <0.001
Depression 10.7% 13.2% 0.007
Psychoses 3.9% 2.6% 0.034
Alcohol abuse 4.5% 3.1% 0.021
Drug Abuse 3.1% 1.8% 0.011
Deficiency anemia 14.7% 12.8% 0.063
Coagulopathy 5.5% 4.0% 0.025
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Metastatic cancer 1.9% 3.1% 0.005
Solid Tumor without Metastasis 1.9% 3.1% 0.005
Diabetes, uncomplicated 29.8% 26.0% 0.005
Oral contraceptive use 0.1% 0.4% 0.009
Renal failure 16.3% 11.5% <0.001
Rhabdomyolysis 1.6% 0.4% <0.001
Fluid and electrolyte Disorders 27.6% 20.3% <0.001
Liver Disease 1.7% 1.3% 0.334
Obesity 11.4% 10.6% 0.356
TABLE 1: Baseline characteristics of hospitalized acute ischemic stroke patients
without versus with cocaine.
Significant P-values ≤ 0.05 at 95% confidence interval, variables were Agency for Healthcare Research and Quality (AHRQ)
comorbidity measures.
Abbreviations: AIS= acute ischemic strokes, SNF= skilled nursing facility, INF= intermediate nursing facility, RA= rheumatoid
arthritis, CVD= collagen vascular diseases.
Multivariable risk factors for acute ischemic strokes
hospitalization
Table 2 shows different variables that were used in the multivariate logistic regression model to
identify AIS risk factors requiring hospitalization. We found cocaine use to be the major risk
factor for hospitalization. In-hospital mortality was also observed to be higher in cocaine
cohort with the 95% confidence interval (CI) 1.1-1.9 (OR= 1.4, 95% CI= 1.1-1.9, p <0.003). A
disposition to short-term hospitals (OR= 2.6, 95% CI= 2.1-3.3, p <0.001) and home healthcare
(OR= 1.5, 95% CI= 1.2-1.9, p <0.001) was also significantly higher after adjusting for
confounders. Personal history of sudden cardiac arrests (OR= 7.9, 95% CI= 3.1-20.1, p <0.001)
were significantly associated with cocaine use which could be another manifestation due to
potential vasospasm [8]. Venous thromboembolism was observed to be linked with cocaine use
(OR= 1.5, 95% CI= 1.0-2.1, p < 0.01), but less severely than vasculitis (OR= 3.0, 95% CI= 1.6-5.8,
p<0.001) (Table 2).
Variables Odds Ratio 95% CI 99% CI P-value*
Weekend Admissions
Monday-Friday Referent Referent Referent  
Saturday-Sunday 0.952 0.827 - 1.096 0.791 - 1.145 0.492
Disposition of Patient
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Routine Referent Referent Referent  
To Short-term Hospitals 2.691 2.143 - 3.380 1.995 - 3.630 <0.001
Other (SNF, ICF, Another Facility) 0.970 0.809 - 1.164 0.764 - 1.233 0.745
Home Health Care 1.574 1.291 - 1.920 1.213 - 2.043 <0.001
Against Medical Advice (AMA) 1.370 0.719 - 2.610 0.587 - 3.196 0.338
Died 1.485 1.147 - 1.922 1.058 - 2.084 0.003
Elective versus Non-elective Admissions
Non-elective 0.374 0.238 - 0.588 0.206 - 0.678 <0.001
Elective Referent Referent Referent  
Indicator of Sex
Male Referent Referent Referent  
Female 0.966 0.849 - 1.098 0.816 - 1.144 0.597
Length of stay (cleaned)
1 to 3 days Referent Referent Referent  
4 to 6 days 0.776 0.661 - 0.910 0.629 - 0.957 0.002
7 to 9 days 1.074 0.876 - 1.316 0.822 - 1.403 0.493
10 to 12 days 1.159 0.886 - 1.515 0.815 - 1.649 0.281
≥13 days 1.252 0.988 - 1.588 0.917 - 1.711 0.063
Primary Expected Payer
Medicare 1.311 0.694 - 2.476 0.568 - 3.024 0.405
Medicaid 1.757 0.904 - 3.415 0.733 - 4.208 0.097
Private including HMO 1.048 0.548 - 2.002 0.447 - 2.454 0.888
Self - Pay 0.635 0.262 - 1.544 0.198 - 2.040 0.317
Other Referent Referent Referent  
Race
White 9.310 3.854 - 22.488 2.921 - 29.668 <0.001
Black 3.883 1.563 - 9.648 1.174 - 12.842 0.003
Hispanic 6.792 2.688 - 17.158 2.009 - 22.958 <0.001
Other Referent Referent Referent  
Median Household Income Quartile on Patient’s ZIP
$ 1 - $ 39, 999 0.610 0.489 - 0.761 0.456 - 0.815 <0.001
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$ 40, 000 - $ 50,999 0.734 0.615 - 0.876 0.582 - 0.926 <0.001
$ 51, 000 - $ 65, 999 0.977 0.843 - 1.133 0.805 - 1.186 0.759
$ 66, 000 + Referent Referent Referent  
Bed Size of Hospital
Small 1.426 1.225 - 1.662 1.167 - 1.743 <0.001
Medium 1.158 1.001 - 1.340 0.957 - 1.402 0.048
Large Referent Referent Referent  
Location and Teaching Status of Hospital
Rural 1.573 1.244 - 1.989 1.156 - 2.141 <0.001
Urban - non teaching 1.061 0.909 - 1.238 0.866 - 1.299 0.452
Urban - teaching Referent Referent Referent  
Control/ownership of Hospital
Government, non-federal 0.198 0.077 - 0.505 0.058 - 0.678 <0.001
Private, non profit 1.306 0.944 - 1.805 0.853 - 1.999 0.107
Private, invest -own Referent Referent Referent  
Co –morbidities#
Musculoskeletal
RA/CVD 1.464 1.039 - 2.063 0.933 - 2.297 0.029
Connective Tissue Disorder 0.800 0.392-1.632 0.313- 2.042 0.539
Cardiovascular
Congestive Heart Failure 1.156 0.971 - 1.376 0.919 - 1.453 0.104
Atherosclerosis 0.789 0.681 - 0.913 0.651 - 0.956 <0.001
AMI 0.841 0.622 - 1.137 0.566 - 1.249 0.259
Arrhythmia 2.744 1.093 - 6.886 0.819 - 9.194 0.032
Sudden Cardiac Death 7.950 3.135 - 20.163 2.340 - 27.013 <0.001
SupraVentricular Premature Beats 2.478 1.009 - 6.085 0.761 - 8.070 0.048
Cardiac Circulatory Anomalies 0.280 0.149 - 0.525 0.122 - 0.640 <0.001
Cardiomyopathy 1.085 0.832 - 1.415 0.766 - 1.538 0.546
Tachycardia 0.867 0.357 - 2.107 0.270 - 2.785 0.753
Heart Valve Disorders 0.679 0.363 - 1.270 0.298 - 1.546 0.226
Peripheral Vascular Disorders 1.200 0.989 - 1.456 0.931 - 1.547 0.065
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Vasculitis 3.077 1.609 - 5.886 1.312- 7.217 <0.001
Hypertension 0.982 0.846 - 1.139 0.807- 1.194 0.807
Elevated Cholesterol 0.642 0.564 - 0.731 0.541 - 0.761 <0.001
Aortic and Peripheral Arterial Embolism or Thrombosis 0.682 0.278 - 1.670 0.210 - 2.214 0.402
Venous Thromboembolism 1.518 1.097 - 2.100 0.991- 2.326 0.012
Respiratory
Chronic Pulmonary Disease 0.895 0.752 - 1.064 0.712 - 1.123 0.207
Pneumothorax (pleurisy) 0.944 0.677 - 1.316 0.610 - 1.460 0.733
Pulmonary Circulation Disorders 1.133 0.852 - 1.507 0.779 - 1.649 0.391
Neurological
Paralysis 0.695 0.540 - 0.895 0.499 - 0.969 0.005
Family History of Stroke 0.270 0.112 - 0.654 0.085 - 0.864 0.004
Meningitis 1.951 0.786 - 4.842 0.591 - 6.443 0.150
Migraine 1.157 0.833 - 1.607 0.752 - 1.782 0.383
Epilepsy 1.563 1.266 - 1.930 1.185 - 2.062 <0.001
Other Neurological Disorders 0.469 0.320 - 0.687 0.284 - 0.775 <0.001
Psychiatry
Depression 1.486 1.243 - 1.777 1.175 - 1.880 <0.001
Psychoses 0.832 0.575 - 1.205 0.512 - 1.354 0.331
Alcohol abuse 0.761 0.535 - 1.082 0.479 - 1.208 0.128
Drug Abuse 0.964 0.603 - 1.541 0.521 - 1.786 0.879
Hemato-oncological
Deficiency Anemia 1.061 0.878 - 1.281 0.827 - 1.360 0.542
Chronic Blood Loss Anemia 1.071 0.437 - 2.626 0.330 - 3.480 0.880
Coagulopathy 0.811 0.593 - 1.109 0.538 - 1.224 0.190
Weight Loss 1.308 0.986 - 1.736 0.902 - 1.898 0.063
Metastatic Cancer 1.052 0.722 - 1.533 0.642 - 1.725 0.791
Solid Tumor without Metastasis 1.109 0.764 - 1.610 0.680 - 1.810 0.585
Lymphoma 0.553 0.228 - 1.343 0.173 - 1.774 0.191
Endocrinological
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Diabetes, Uncomplicated 0.981 0.847 - 1.136 0.809 - 1.190 0.799
Diabetes with Chronic Complications 1.191 0.926 - 1.531 0.856 - 1.656 0.173
Oral Contraceptive Use 8.277 3.247 - 21.097 2.420 - 28.308 <0.001
Hypothyroidism 0.749 0.617 - 0.909 0.581 - 0.966 <0.003
Renal
Acute Renal Failure 1.539 1.278 - 1.852 1.205 - 1.964 <0.001
Rhabdomyolysis 0.224 0.092 - 0.544 0.070 - 0.718 <0.001
Fluid and Electrolyte Disorders 0.612 0.518 - 0.725 0.491 - 0.764 <0.001
Gastrointestinal
Liver Disease 0.913 0.540 - 1.544 0.458 - 1.821 0.734
Obesity 1.255 1.027 - 1.533 0.965 - 1.633 0.026
TABLE 2: Predictors of hospitalization in acute ischemic strokes (AIS) cocaine cohort
versus acute ischemic strokes (AIS) on cocaine cohort by multivariate logistic
regression.
Significant P-value ≤ 0.05 at 95% and ≤ 0.01 at 99% confidence interval, variables are Agency for Healthcare Research and
Quality (AHRQ) co-morbidity measures.
Abbreviations: SNF= skilled nursing facility, INF= intermediate nursing facility, RA= rheumatoid arthritis CVD= collagen vascular
diseases, CI= confidence interval, HMO= Health Maintenance Organization.
Gender comparison of cocaine-associated mortality
Table 3 shows the gender comparison in co-morbidities associated mortality in the cocaine
cohort. Higher overall mortality due to cardiac (except arrhythmia and supraventricular
premature beats) causes and acute renal failure was observed in males, whereas females had
increased overall mortality owing to elevated cholesterol, heart valve disorders, vasculitis,
epilepsy, arrhythmia, supraventricular premature beats (SVPB), peripheral arterial
thromboembolism and heart valve disorders. A similar rate of mortalities between males and
females was found due to events of elevated blood pressure without hypertension (which could
be owing to incidental cocaine intake) and acute cerebrovascular disease.
Comorbidities and predictors of mortality
Died
P-value
Male Female
Cocaine use 0.2% 0.3% 0.160
Cardiomyopathy 11.9% 9.0% <0.001
Acute myocardial infarction 15.5% 13.7% <0.001
Atherosclerosis 36.0% 27.4% <0.001
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Acute renal failure 40.7% 31.3% <0.001
Arrhythmia 0.2% 0.4% <0.001
Supraventricular Premature Beats 0.1% 0.2% <0.001
Sudden cardiac death 0.6% 0.3% <0.001
Cardiac and circulatory anomalies 2.2% 1.5% <0.001
Transient ischemic attacks 0.6% 0.5% <0.001
Tachycardia 1.9% 1.8% <0.001
Elevated BP without hypertension 0.1% 0.1% <0.001
Pneumothorax and pleurisy 12.3% 9.8% <0.001
Bronchiolitis obliterans organizing pneumonia 0.1% 0.1% <0.001
Rhabdomyolysis 4.3% 3.0% <0.001
Elevated cholesterol and lipids 35.1% 35.3% <0.001
Meningitis 1.2% 0.7% <0.001
Migraine 0.6% 1.3% <0.001
Sickle cell disease 0.1% 0.2% <0.001
Oral contraceptive use 0.0% 0.1% 0.472
Viral infection 1.0% 0.6% <0.001
Heart valve disorder 11.3% 12.2% <0.001
Vasculitis 0.4% 0.6% <0.001
Connective tissue disorder 0.2% 1.1% 0.107
Aortic, peripheral arterial thromboembolism 1.6% 2.0% <0.001
Acute vascular insufficiency of intestine 0.9% 0.6% <0.001
Epilepsy 11.9% 12.2% <0.001
Family History Stroke (cerebrovascular) 0.6% 0.7% <0.001
Acute but ill-defined cerebrovascular disease 0.4% 0.4% <0.001
Drug induced headache 0.0% 0.0% 0.071
TABLE 3: Gender comparison in comorbidities associated mortality in acute ischemic
stroke (AIS) cocaine cohort.
Multivariable predictors of mortality
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Variables No Cocaine Cocaine
 
Odds
ratio
99% Confidence
Interval
P-
value*
Odds
ratio
99% Confidence
Interval
P-
value*
Co – morbidities#
Deficiency anemias 0.899 0.866 0.933 <0.001 1.809 0.622 5.258 0.153
Congestive heart failure 1.540 1.487 1.596 <0.001 0.506 0.174 1.471 0.100
Chronic pulmonary disease 1.125 1.085 1.166 <0.001 1.078 0.431 2.694 0.833
Coagulopathy 1.720 1.644 1.800 <0.001 0.378 0.042 3.428 0.256
Depression 0.751 0.713 0.791 <0.001 0.191 0.048 0.753 0.002
Diabetes, uncomplicated 0.891 0.862 0.921 <0.001 0.364 0.156 0.850 0.002
Hypertension 0.725 0.701 0.749 <0.001 0.302 0.119 0.765 0.001
Hypothyroidism 1.031 0.990 1.074 0.052 1.521 0.527 4.395 0.308
Liver disease 1.210 1.107 1.322 <0.001 12.608 1.255 126.656 0.005
Fluid and electrolyte disorders 1.582 1.534 1.632 <0.001 1.046 0.430 2.546 0.896
Metastatic cancer 1.921 1.787 2.065 <0.001 4.895 1.318 18.184 0.002
Other neurological disorders 1.129 1.074 1.187 <0.001 0.461 0.064 3.314 0.312
Obesity 0.754 0.717 0.793 <0.001 0.694 0.204 2.356 0.441
Paralysis 1.494 1.437 1.553 <0.001 0.929 0.269 3.207 0.879
Peripheral vascular disorders 1.145 1.097 1.196 <0.001 3.405 1.296 8.947 0.001
Pulmonary circulation disorders 1.268 1.195 1.345 <0.001 0.295 0.075 1.157 0.021
Renal failure 1.077 1.037 1.119 <0.001 0.775 0.222 2.702 0.599
Solid tumor without
metastasis           
1.279 1.174 1.394 <0.001 0.534 0.075 3.785 0.409
Weight loss 1.263 1.206 1.323 <0.001 0.959 0.296 3.107 0.927
Cardiomyopathy 1.076 1.024 1.132 <0.001 3.008 0.844 10.722 0.026
Acute myocardial infarction 2.431 2.323 2.544 <0.001 7.820 2.173 28.138 <0.001
Table 4 shows the comparison of various comorbidity related mortality odds between cocaine
and non-cocaine cohorts. Mortality odds owing to liver disease, metastatic cancer,
cardiomyopathy, acute myocardial infarction, and epilepsy were increased in both non-cocaine
and cocaine cohort. Whereas, increased odds of mortality in the non-cocaine cohort were
observed due to coagulopathy, disorders of fluid and electrolyte, obesity, weight loss, solid
tumor without metastasis, elevated cholesterol, pneumothorax and pleurisy and congestive
heart failure. Effect on mortality due to other variables is shown in Table 4.
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Atherosclerosis 1.071 1.037 1.106 <0.001 0.844 0.371 1.918 0.594
Tachycardia 1.950 1.746 2.179 <0.001 2.133 0.131 34.728 0.484
Elevated Cholesterol and lipid 0.558 0.541 0.575 <0.001 0.815 0.325 2.042 0.566
Pneumothorax and pleurisy 1.622 1.542 1.706 <0.001 0.263 0.048 1.449 0.044
Epilepsy 1.479 1.412 1.550 <0.001 9.322 3.721 23.355 <0.001
TABLE 4: Multivariate predictors of the mortality in acute ischemic stroke patients
without cocaine use versus with cocaine use
Significant P-values ≤ 0.05 at 95% and  ≤ 0.01 at 99% confidence interval, variables are Agency for Healthcare Research and
Quality (AHRQ) co-morbidity measures.
Discussion
The current study found 96.5% of the AIS cocaine cohort was of the age group above 45 years
with age ranging from 18 years to 85 years and above. In the age group of 85 years and above,
the prevalence of AIS within the cocaine group surpassed the non-cocaine users. A plausible
explanation could be that the cumulative effect of traditional risk factors, along with the long-
term accumulation of chronic cocaine effect makes such population more vulnerable towards
the risk of stroke [2]. The frequency of hospitalization was high among the urban hospitals set
up.
A majority of the AIS patients visited the private, nonprofit hospitals. Among these, the odds of
ones with cocaine use visiting the government, non-federal hospital were significantly low. The
nature of the admission was nonelective understandable for most of the AIS cohort and within
this cohort; it was significantly higher among the cocaine users. It could be because most of the
patients are chronic cocaine abusers rather than acute. This finding is also justifiable from the
older age group pattern of the study subject which is prone to the cumulative effect of the
cocaine rather than acute features [2]. Odds of hospitalization among the whites were higher
compared to the blacks and Hispanics in AIS cocaine cohort versus AIS non-cocaine cohort.
The mortality was found higher in blacks as compared to whites and Hispanic (21.4% versus
8.6% versus 11.1%, P=0.004 respectively). Analyzing the disposition of the patients, the short-
term hospitals stay and death was significantly higher among the cocaine users. The associated
higher comorbidities could be a possible explanation for such disposition in cocaine users as
compared to the non-cocaine group. This finding is a serious concern because such patients
could lead to a significant burden on the healthcare infrastructure. With increasing median
household income, the frequency of hospitalization significantly increased among the cocaine
users suggesting that the ones with low income and living in a poverty have a lower risk of
using cocaine. Another reason could be that socioeconomic status is the poor predictor of the
stroke among the cocaine users. Despite having high median household income among the
cocaine users, their hospitalization was significantly elevated in the small and medium-sized
hospitals. This could be due to the acute nature of the condition among these subjects,
requiring urgent admission to any of the nearby facility.
The family history of the stroke was higher among the non-cocaine users as compared to the
cocaine users suggesting that the usual mechanism of stroke development is not applicable to
the cocaine user. Cocaine users quite commonly bear the traditional cardiovascular risk factors
[2]. Sudden cardiac death, paroxysmal supraventricular tachycardia (PSVT), vasculitis and
venous thromboembolism take higher odds of hospitalization.
2017 Desai et al. Cureus 9(8): e1536. DOI 10.7759/cureus.1536 13 of 17
Odds of hospitalization due to the paralysis were significantly higher among the non-cocaine
users while seizures were high among the cocaine users. The frequency of depression was
significantly higher among the cocaine abusers signifying the high morbidity among such
populations. The incidence of diabetes and congestive heart failure (CHF) was severely high
among the cocaine users, while the frequency of hypertension was quite similar to the other
studies [2].
There was a significantly higher rate of valvular heart disease and venous thromboembolism
among the cocaine users, suggesting of emboli as the major risk for stroke among these
populations as compared to the non-cocaine users [15-17]. We reported the higher mortality
among the cocaine users as compared to the non-cocaine users [18].
The older age of our study population could be a plausible reason, as studies with the young
demographic and mild strokes have reported overall low mortality [19]. When we looked for the
multivariate predictors of death in the AIS patients without cocaine use and with cocaine use,
we found that epilepsy, peripheral vascular disorders, acute myocardial infarction,
cardiomyopathy, tachycardia, metastatic cancer and liver diseases were associated with higher
odds of mortality among cocaine users as compared to the non-cocaine users.
Hypertension and diabetes were not found to be associated with the excess mortality in an AIS
cocaine cohort compared to the AIS non-cocaine cohort. Several postulated mechanisms for
cocaine-induced ischemic stroke has been suggested [20-23]. Among these, the cardioembolic
ischemic strokes and cardiac deaths due to chronic cocaine use have been proposed to be
prominent [17, 24]. 
Study limitations
This study has undeniable limitations because of the NIS database which might have coding
errors in terms of determining the diagnosis, comorbidities, and complications. Due to the
inherent nature of large hospital’s database, it may over or underestimate AIS, cocaine use,
comorbidities and other clinically relevant variables based on ICD-9 CM codes. This study also
lacked variables such as medications and other treatment options related to AIS.
This database does not mention about the cause of death, so we cannot differentiate between
in-hospital events and cause of death. It might be possible to have a selection bias in this study
because of a retrospective population study. Due to large data size and getting national
estimates using discharge weight as provided by NIS database, we could overcome these
limitations. 
Conclusions
To our knowledge, this is one of the very few studies demonstrating the effects of cocaine use
on stroke using the nationally representative data source. Our results displaying the amplitude
of the mortality in an AIS-cocaine cohort raised the question whether to consider cocaine as a
risk factor in all AIS patients or not. Further research is warranted to evaluate the pathogenesis
and health care burden due to cocaine-induced stroke.
Appendices
Table 5 has the list of ICD-9-CM codes for suspected risk factors of AIS, comorbidities, in-
hospital procedures and outcomes.
Risk Factors/ Co-morbidity Source Codes
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Acute ischemic stroke ICD-9
433.01, 433.10, 433.11, 433.21, 433.31, 433.81, 433.91, 434.00,
434.01, 434.11, 434.91, 436
Cocaine ICD - 9 304.20, 304.21, 304.22, 305.60  305.61, 305.62
Acute myocardial infarction CCS 100
Peri-; endo-; and myocarditis, cardiomyopathy CCS 97
Sudden cardiac death ICD - 9 V12.53
Arrhythmias ICD - 9 427.9
Supraventricular premature beats ICD - 9 427.61
Tachycardia, unspecified ICD - 9 785.0
Elevated blood pressure reading without
diagnosis of hypertension
ICD - 9 796.2
Rhabdomyolysis ICD - 9 728.88
Acute and unspecified renal failure CCS 157
Bronchiolitis Obliterans organizing pneumonia ICD - 9 516.8
Pleurisy; pneumothorax; pulmonary collapse CCS 130
Epilepsy CCS 83
Drug induced headache, not elsewhere classified ICD - 9 339.3
Family Hx Stroke (cerebrovascular) ICD - 9 V17.1
Acute vascular insufficiency of intestine ICD – 9 557.0
Aortic and peripheral arterial embolism or
thrombosis
CCS 116
Unspecified venous complication ICD – 9 671.9
Venous thrombosis and embolism ICD - 9 V12.51
Connective tissue diseases CCS 210
Vasculitis ICD - 9 447.6; 446.0–446.9
Meningitis CCS 76
Cardiac and circulatory anomalies CCS 213
Elevated cholesterol and lipids CCS 53
Migraine CCS 84
Sickle cell disease CCS 61
Viral infection CCS 7
Heart valve disorder CCS 96
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Atherosclerosis CCS 114
Acute but ill-defined cerebrovascular disease CCS 109
Transient ischemic attack CCS 112
Oral contraceptive use CCS 176
TABLE 5: International Classification of Disease, Ninth Revision (ICD-9) codes and
the Clinical Classifications Software (CCS) codes used to identify co-morbidities, in-
hospital procedures and complications.
Abbreviations: ICD‐9‐CM= International Classification of Diseases, Ninth Revision, Clinical Modification; CCS= Clinical
Classification Software.
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